Biomarcadors en Fluids i Neurologia Translacional Marc Suárez-Calvet

Publicacions 2024 (23)

Fortea J^*, Vaqué-Alcazar L, Pegueroles J, Alcolea D, Belbin O, Dols Icardo O, Videla L, Gispert JD, Suarez-Calvet M, Johnson SC, Sperling R, Bejanin A, Lleó A, Montal V. Reply to: Challenges to identifying risk versus protective factors in Alzheimer's disease. Nat Med 2024: (en Premsa).
Warmenhoven N, Sánchez-Benavides G, Gonzalez-Escalante A, Milà M, Shekari M, López D, Ortiz-Romero P, Kollmorgen G, Quijano-Rubio C, Minguillón C, Gispert JD, Vilor-Tejedor N, Arenaza-Urquijo EM, Palpatzis E, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M^*, Grau-Rivera O, ALFA Study. CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease. Alzheimers Dement 2024: (en Premsa).
Vila-Castelar C, Akinci M, Palpatzis E, Aguilar-Dominguez P, Operto G, Kollmorgen G, Quijano-Rubio C, Blennow K, Zetterberg H, Falcon C, Fauria K, Gispert JD, Grau-Rivera O, Suarez-Calvet M, Arenaza-Urquijo EM, ALFA study (...,Hernandez-Villamizar F, López D, Lugo F, Marne P, Menchon T, Minguillón C, Sánchez-Benavides G, Shekari M, Vilor N,...). Sex/gender effects of glial reactivity on preclinical Alzheimer's disease pathology. Mol Psychiatr 2024: (en Premsa).
Vermunt L^*, Sutphen CL, Dicks E, de Leeuw DM^*, Allegri RF, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Day GS, Ewers M, Farlow MR, Fox NC, Ghetti B, Graff-radford NR, Hassenstab J, Jucker M, Karch CM, Kuhle J, Laske C, Levin J, Masters CL, Mcdade E, Mori H, Morris JC, Perrin RJ, Preische O, Schofield PR, Suarez-Calvet M, Xiong C, Scheltens P, Teunissen CE, Visser PJ, Bateman RJ, Benzinger TLS, Fagan AM, Gordon BA, Tijms BM, on behalf of the Dominantly Inherited Alzheimer Network. Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's disease. Brain Commun . 2024; 6(5): fcae357 (Acceptat).
Contador J, Suarez-Calvet M^*. Blood-based biomarkers in the oldest old: towards Alzheimer's disease detection in primary care. Lancet Reg Health Eur . 2024; 45: 101077 (Acceptat).
Del Campo M^*, Quesada-González C, Vermunt L, Peeters CFW, Hok-a-hin YS, Trieu C, Den Braber A, Verberk IMW, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE. CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals. Mol Neurodegener 2024; 19(1): 82.
Therriault J^*, Janelidze S, Benedet AL, Ashton NJ, Arranz-Martínez J, Gonzalez-Escalante A, Bellaver B, Alcolea D, Vrillon A, Karim H, Mielke MM, Hyung Hong, Roh HW, Contador J, Puig-Pijoan A, Algeciras-Schimnich A, Vemuri P, Graff-Radford J, Lowe VJ, Karikari TK, Jonaitis E, Brum W, Tissot C, Servaes S, Rahmouni N, Macedo AC, Stevenson J, Fernandez-Arias J, Wang YT, Woo MS, Friese MA, Jia WL, Dumurgier J, Hourregue C, Cognat E, Ferreira PL, Vitali P, Johnson SC, Pascoal TA, Gauthier S, Lleó A, Paquet C, Petersen RC, Salmon D, Mattsson-Carlgren N, Palmqvist S, Stomrud E, Galasko D, Son SJ, Zetterberg H, Fortea J, Suarez-Calvet M, Jack CR, Blennow K, Hansson O, Rosa-Neto P^*. Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability. Nat Aging. 2024; 4(11): 1529-1537.
Schöll M^*, Verberk IMW, Del Campo M, Delaby C, Therriault J, Chong JR, Palmqvist S, Alcolea D^*. Challenges in the practical implementation of blood biomarkers for Alzheimer's disease. Lancet Healthy Longev . 2024; 5(10): 100630.
Gonzalez-Ortiz F^*, Kirsebom BE, Contador J, Tanley JE, Selnes P, Gísladóttir B, Pålhaugen L, Suhr-Hemminghyt M, Jarholm J, Skogseth R, Bråthen G, Grøndtvedt G, Bjørnerud A, Tecelao S, Waterloo K, Aarsland D, Fernández A, García-Escobar G, Navalpotro I, Turton M, Hesthamar A, Kac PR, Nilsson J, Luchsinger J, Hayden KM, Harrison P, Puig-Pijoan A, Zetterberg H, Hughes TM, Suarez-Calvet M, Karikari TK, Fladby T, Blennow K. Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease. Nat Commun 2024; 15(1): 2908.
Lázaro López I, Grau-Rivera O, Suarez-Calvet M, Fauria K, Minguillón C, Shekari M, Falcón C, García-Prat M, Huguet J, Molinuevo JL, Gispert JD^*, Sala-Vila A^*, ALFA study. Omega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia. Alzheimers Dement 2024; 16(3): e12596 (Acceptat).
Ritchie C^*, Blennow K, Gispert JD, Johnson SC, van Maurik IS, Vermunt L, Suarez-Calvet M, Mchugh CP, Clement MHS, Anastasiu A, Rosenfeld E, Cosma O, Logan CA, Quevenco FC, Dias MC, Carboni M. NeuroToolKit Data Hackathon: advancing data collaboration in Alzheimer's disease. Front Neurosci . 2024; 18: 1339742 (Acceptat).
Falcon C, Montesinos P, Václavu L, Kassinopoulos M, Minguillón C, Fauria K, Cascales D, Contador J, Fernández A, Navalpotro I, Puig-Pijoan A, Grau-Rivera O, Kollmorgen G, Quijano-Rubio C, Molinuevo JL, Zetterberg H, Blennow K, Suarez-Calvet M, Van Osch MJP, Sanchez-Gonzalez J, Gispert JD^*. Time-encoded ASL reveals lower cerebral blood flow in the early AD continuum. Alzheimers Dement 2024; 20(8): 5183-5197.
López D, Suarez-Calvet M, Milà M, Gispert JD, Minguillón C, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Blennow K, Grau-Rivera O^*, Sánchez-Benavides G^*. Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer's continuum. Front Aging Neurosci . 2024; 16: 1394460 (Acceptat).
Palpatzis E, Akinci M, Aguilar-Dominguez P, García-Prat M, Blennow K, Zetterberg H, Carboni M, Kollmorgen G, Wild N, Fauria K^*, Falcón C, Gispert JD, Suarez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM^*, ALFA study. Lifetime Stressful Events Associated with Alzheimer's Pathologies, Neuroinflammation and Brain Structure in a Risk Enriched Cohort. Ann Neurol 2024; 95(6): 1058-1068.
Fortea J^*, Pegueroles J, Alcolea D, Belbin O, Dols Icardo O, Vaqué-Alcazar L, Videla L, Gispert JD, Suarez-Calvet M, Johnson SC, Sperling R, Bejanin A, Lleó A, Montal V^*. APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nat Med 2024; 30(5): 1284-1291.
He R^*, Al-Tamimi J, Sánchez-Benavides G, Montaña-Valverde G, Gispert JD, Grau-Rivera O, Suarez-Calvet M, Minguillón C, Fauria K, Navarro A, Hinzen W. Atypical cortical hierarchy in A?-positive older adults and its reflection in spontaneous speech. Brain Res 2024; 1830: 148806.
Cumplido-Mayoral I, Brugulat-Serrat A, Sánchez-Benavides G, Gonzalez-Escalante A, Anastasi F, Milà M, López D, Akinci M, Falcon C, Shekari M, Cacciaglia R, Arenaza-Urquijo EM, Minguillón C, Fauria K, Molinuevo JL, Suarez-Calvet M, Grau-Rivera O, Vilaplana V, Gispert JD^*, ALFA study. The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study. Lancet Healthy Longev . 2024; 5(4): e276-e286.
Jiang Y, Uhm H, Ip FC, Ouyang L, Lo RMN, Cheng EYL, Cao X, Tan CMC, Law BCH, Ortiz-Romero P, Puig-Pijoan A, Fernández A, Contador J, Mok KY, Hardy J, Kwok TCY, Mok VCT, Suarez-Calvet M, Zetterberg H, Fu AKY, Ip NY^*. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups. Alzheimers Dement 2024; 20(3): 2000-2015.
Vilor-Tejedor N^*, Genius P, Rodriguez-Fernandez B, Minguillón C, Sadeghi I, Gonzalez-Escalante A, Crous M, Suarez-Calvet M, Grau-Rivera O, Brugulat-Serrat A, Sánchez-Benavides G, Esteller M, Fauria K, Molinuevo JL, Navarro A, Gispert JD^*, ALFA study. Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum. Alzheimers Dement 2024; 20(3): 1703-1715.
Gonzalez-Ortiz F^*, Ferreira PCL, Gonzalez-Escalante A, Montoliu-Gaya L, Ortiz-Romero P, Kac PR, Turton M, Kvartsberg H, Ashton NJ, Zetterberg H, Harrison P, Bellaver B, Povala G, Villemagne VL, Pascoal TA, Ganguli M, Cohen AD, Minguillón C, Contador J, Suarez-Calvet M, Karikari TK, Blennow K^*. A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease. Alzheimers Dement 2024; 20(2): 1239-1249.
Pelkmans W^*, Shekari M, Brugulat-Serrat A, Sánchez-Benavides G, Minguillón C, Fauria K, Molinuevo JL, Grau-Rivera O, Gonzalez-Escalante A, Kollmorgen G, Carboni M, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M, Gispert JD^*, ALFA study. Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression. Alzheimers Dement 2024; 20(1): 483-493.
García-Escobar G, Manero RM, Fernández A, Ois A^*, Navalpotro I, Puente VM, Contador J, Estragues Gazquez I, Puig-Pijoan A, Jiménez J. Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review. Biomolecules 2024; 14(1): 93.
Puig-Pijoan A^*, Jiménez J^*, Fernández A, García-Escobar G, Navalpotro I, Contador J, Manero RM, Puente VM, Suarez A, Muñoz-López FJ, Grau-Rivera O, Suarez-Calvet M, de la Torre R, Roquer-González J, Ois A^*. Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: A longitudinal study in a memory unit clinical cohort. Alzheimers Dement 2024; 20(1): 538-548.